AI Article Synopsis
- Recent MAGNIMS-CMSC-NAIMS recommendations on MRI use in multiple sclerosis (MS) have been crucial for enhancing patient treatment.
- Implementation of these guidelines is inconsistent across various countries, indicating the need to tackle local challenges.
- A group of 14 MS neurologists from 16 centers in Latin America convened to evaluate MRI access, standardization of protocols, and opportunities for collaborative research in MS.
Article Abstract
MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis have been recently published, and they have been fundamental for improving patient care. Implementation of these and previous MAGNIMS recommendations have not been established in many countries. Addressing the local limitations behind these difficulties is needed. A panel of 14 MS neurologists from 16 different reference centres from Chile, Argentina, Mexico, Colombia, Ecuador, Panamá, Perú and Brazil met to discuss the current situation regarding the use of MRI in MS including a) Access and availability, b) Standardized acquisition protocols and reports, and c) Multicentric research potential.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.msard.2022.103649 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!